NEULANDLABBSENeuland Laboratories Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 9 Jun, 2025 · 12:12 IST

The Exchange has sought clarification from Neuland Laboratories Ltd on June 9, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.

Regulatory & LegalExplain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹12900.00
prior close
₹12981.00
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%-2.8% vs market
Pharmaceuticals peers, median of 151sector+0.5%-2.0% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Smallcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-0.1
15m
-0.2
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5+1.3-2.8+0.5-2.0
Next day
-1.7+1.5-3.2+1.1-2.8
2d
+4.9+1.4+3.5+1.6+3.4
3d
+3.3-0.1+3.4+1.4+1.9
4d
+3.0-0.4+3.4+1.0+2.0
5d
-0.9+0.1-1.0+0.7-1.6
1w
-4.7-0.8-3.9-1.3-3.4
15d
-6.9+3.0-9.9-0.2-6.7
1m
-7.0+2.9-9.9-0.4-6.7
2m
+3.0-3.9+6.9-3.0+6.0
3m
+11.8-1.8+13.5-2.2+13.9
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Bombay Stock Exchange (BSE) has asked Neuland Laboratories Ltd to explain the recent unusual movement in the trading volume of its shares. The clarification request was sent on June 9, 2025. The company has not yet responded, and its reply is awaited. This is a routine query that exchanges typically send when a stock sees abnormal trading activity, to check if there is any undisclosed price-sensitive information. There is no indication of any regulatory action, penalty, or investigation at this stage.

Likely market impact

This is a standard exchange clarification and not a punitive action. Investors should watch for the company's response, as the explanation could clarify whether the volume spike was due to any material development or was purely market-driven. In the absence of a reply, the stock may see some short-term uncertainty but is unlikely to be materially affected.